Nabi Biopharmaceuticals (NABI) Tops Q2 EPS by 5c
Tweet Send to a Friend
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q2 EPS of ($0.06), $0.05 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
